Enzo Biochem Inc ENZ:NYSE

RT Quote | Last NYSE, VOL From CTA | USD
Last | 1:31 PM EST
3.00quote price arrow up+0.05 (+1.69%)
Volume
125,754
52 week range
1.56 - 4.85

...

Loading . . .

KEY STATS

  • Open3.08
  • Day High3.08
  • Day Low2.92
  • Prev Close2.95
  • 52 Week High4.85
  • 52 Week High Date03/09/20
  • 52 Week Low1.56
  • 52 Week Low Date03/18/20
  • Market Cap143.70M
  • Shares Out47.90M
  • 10 Day Average Volume0.28M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • 1 Year % Change39.72

RATIOS/PROFITABILITY

  • EPS (TTM)-0.43
  • P/E (TTM)-6.96
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-13.279M
  • ROE (MRQ)-29.96%
  • Revenue (MRQ)84.47M
  • Gross Margin (MRQ)35.49%
  • Net Margin (MRQ)-24.36%
  • Debt To Equity (MRQ)19.87%

EVENTS

  • Earnings Date03/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Enzo Biochem Inc News

There is no recent news for this security.

Latest ENZ News From Our Partners

QUOTE FINDER

Profile

MORE
Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or...
Elazar Rabbani Ph.D.
Chief Executive Officer
Barry Weiner
President
David Bench
Chief Financial Officer
Address
60 EXECUTIVE BLVD
Farmingdale, NY
11735
United States